Hydroxydaunorubicin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hydroxydaunorubicin, covering 2018-04-25 to 2018-04-25. Get the full timeline:
Most recent: Clinical Trial Update: Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome [Phase 2]